BIOMAT Database Logo BIOMAT Database Logo

Temozolomide presents breakthrough in glioblastoma multiforme treatment. 1999

Sansom
Birkbeck College, University of London, Malet Street, London, UK WC1E 7HX.

UI MeSH Term Description Entries

Related Publications

Sansom
Temozolomide resistance in glioblastoma multiforme.
September 2016, Genes & diseases,
Sansom
Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
January 2007, Anticancer research,
Sansom
Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme.
January 2004, Journal of neuro-oncology,
Sansom
Temozolomide in glioblastoma multiforme of the elderly.
January 2002, Tumori,
Sansom
Combined modality treatment of glioblastoma multiforme: the role of temozolomide.
January 2006, Reviews on recent clinical trials,
Sansom
Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme.
May 2012, Journal of neuro-oncology,
Sansom
Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
June 2014, Annals of the Academy of Medicine, Singapore,
Sansom
Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme.
January 2005, PharmacoEconomics,
Sansom
Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide.
July 1999, Journal of cancer research and clinical oncology,
Sansom
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
May 2012, Expert review of anticancer therapy,
Copied contents to your clipboard!